Alpha Teknova, Inc. (TKNO)
USD 5.8
(0.43%)
USD 5.8
(0.43%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 36.68 Million USD | -11.43% |
| 2022 | 41.42 Million USD | 12.27% |
| 2021 | 36.89 Million USD | 17.88% |
| 2020 | 31.29 Million USD | 55.75% |
| 2019 | 20.09 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 9.29 Million USD | 18.09% |
| 2024 Q2 | 9.61 Million USD | 3.49% |
| 2023 Q2 | 11.52 Million USD | 26.38% |
| 2023 Q1 | 9.12 Million USD | 15.59% |
| 2023 FY | 36.68 Million USD | -11.43% |
| 2023 Q4 | 7.86 Million USD | -3.7% |
| 2023 Q3 | 8.16 Million USD | -29.13% |
| 2022 Q2 | 11.69 Million USD | 4.87% |
| 2022 FY | 41.42 Million USD | 12.27% |
| 2022 Q1 | 11.14 Million USD | 10.26% |
| 2022 Q3 | 10.69 Million USD | -8.54% |
| 2022 Q4 | 7.89 Million USD | -26.2% |
| 2021 Q4 | 10.11 Million USD | 7.64% |
| 2021 Q1 | 9.07 Million USD | -10.62% |
| 2021 FY | 36.89 Million USD | 17.88% |
| 2021 Q2 | 8.31 Million USD | -8.43% |
| 2021 Q3 | 9.39 Million USD | 12.98% |
| 2020 Q1 | 6.11 Million USD | 0.0% |
| 2020 FY | 31.29 Million USD | 55.75% |
| 2020 Q4 | 10.15 Million USD | 13.06% |
| 2020 Q3 | 8.98 Million USD | 48.64% |
| 2020 Q2 | 6.04 Million USD | -1.11% |
| 2019 FY | 20.09 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 566.76 Million USD | 93.527% |
| China SXT Pharmaceuticals, Inc. | 1.92 Million USD | -1802.207% |
| Embecta Corp. | 1.12 Billion USD | 96.727% |
| Pacira BioSciences, Inc. | 674.97 Million USD | 94.565% |
| PainReform Ltd. | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -52.261% |
| SCYNEXIS, Inc. | 140.14 Million USD | 73.824% |
| Journey Medical Corporation | 79.18 Million USD | 53.671% |
| Safety Shot Inc | 202.67 Thousand USD | -18000.36% |
| Bright Green Corporation | 401.49 Thousand USD | -9036.942% |
| Procaps Group, S.A. | 409.92 Million USD | 91.051% |
| Alvotech | 91.43 Million USD | 59.879% |
| ANI Pharmaceuticals, Inc. | 486.81 Million USD | 92.465% |
| Aquestive Therapeutics, Inc. | 50.58 Million USD | 27.478% |
| Cosmos Health Inc. | 53.37 Million USD | 31.274% |
| Dynavax Technologies Corporation | 232.28 Million USD | 84.207% |
| Esperion Therapeutics, Inc. | 116.33 Million USD | 68.467% |
| Intra-Cellular Therapies, Inc. | 464.37 Million USD | 92.1% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -52.261% |
| Theratechnologies Inc. | 81.76 Million USD | 55.134% |
| Harrow Health, Inc. | 130.19 Million USD | 71.823% |
| Sonoma Pharmaceuticals, Inc. | 12.73 Million USD | -188.057% |
| Biofrontera Inc. | 34.07 Million USD | -7.669% |
| DURECT Corporation | 8.54 Million USD | -329.153% |
| Supernus Pharmaceuticals, Inc. | 607.52 Million USD | 93.962% |
| Cronos Group Inc. | 88.84 Million USD | 58.708% |
| OptiNose, Inc. | 70.98 Million USD | 48.323% |
| Ironwood Pharmaceuticals, Inc. | 442.73 Million USD | 91.714% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 6.51 Million USD | -463.228% |
| Organogenesis Holdings Inc. | 433.14 Million USD | 91.531% |
| Guardion Health Sciences, Inc. | 12.24 Million USD | -199.497% |
| Cumberland Pharmaceuticals Inc. | 39.55 Million USD | 7.252% |
| Radius Health, Inc. | 2.88 Billion USD | 98.727% |
| Universe Pharmaceuticals INC | 32.3 Million USD | -13.542% |
| ProPhase Labs, Inc. | 44.38 Million USD | 17.349% |
| Phibro Animal Health Corporation | 1.01 Billion USD | 96.395% |
| Procaps Group S.A. | 409.92 Million USD | 91.051% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -2717.512% |
| Viatris Inc. | 15.42 Billion USD | 99.762% |
| Rockwell Medical, Inc. | 83.61 Million USD | 56.126% |
| Aytu BioPharma, Inc. | 81 Million USD | 54.712% |
| SIGA Technologies, Inc. | 139.91 Million USD | 73.782% |
| Tilray Brands, Inc. | 788.94 Million USD | 95.35% |
| Lifecore Biomedical, Inc. | 128.26 Million USD | 71.399% |
| Shineco, Inc. | 9.8 Million USD | -274.256% |
| PetIQ, Inc. | 1.1 Billion USD | 96.671% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 12 Thousand USD | -305600.0% |
| Neurocrine Biosciences, Inc. | 1.88 Billion USD | 98.056% |
| Alimera Sciences, Inc. | 80.75 Million USD | 54.573% |
| Silver Spike Investment Corp. | 11.72 Million USD | -212.946% |
| Assertio Holdings, Inc. | 152.06 Million USD | 75.877% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 5.82 Million USD | -530.051% |
| Clever Leaves Holdings Inc. | 17.41 Million USD | -110.622% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -3308.011% |
| Avadel Pharmaceuticals plc | 27.96 Million USD | -31.188% |
| Hempacco Co., Inc. | 4.04 Million USD | -806.755% |
| Talphera, Inc. | 651 Thousand USD | -5535.023% |
| Alvotech | 91.43 Million USD | 59.879% |
| Eagle Pharmaceuticals, Inc. | 316.61 Million USD | 88.414% |
| Lantheus Holdings, Inc. | 1.29 Billion USD | 97.17% |
| Currenc Group, Inc. | 53.25 Million USD | 31.117% |
| Kamada Ltd. | 144.75 Million USD | 74.659% |
| Indivior PLC | 1.09 Billion USD | 96.644% |
| Evoke Pharma, Inc. | 5.18 Million USD | -608.099% |
| Flora Growth Corp. | 76.07 Million USD | 51.777% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -3308.011% |
| Evolus, Inc. | 202.08 Million USD | 81.847% |
| HUTCHMED (China) Limited | 837.99 Million USD | 95.622% |
| Amphastar Pharmaceuticals, Inc. | 644.39 Million USD | 94.307% |
| Akanda Corp. | 2.16 Million USD | -1598.292% |